​​​​​​​​Anti-Cancer Drugs reports both clinical and experimental results related to anti-cancer drugs, and welcomes contributions on anti-cancer drug design, drug delivery, pharmacology, hormonal and biological modalities and chemotherapy evaluation. An internationally refereed journal devoted to the fast publication of innovative investigations on therapeutic agents against cancer, Anti-Cancer Drugs aims to stimulate and report research on both toxic and non-toxic anti-cancer agents. Consequently, the scope on the journal will cover both conventional cytotoxic chemotherapy and hormonal or biological response modalities such as interleukins and immunotherapy. Submitted articles undergo a preliminary review by the editor. Some articles may be returned to authors without further consideration. Those being considered for publication will undergo further assessment and peer-review by the editors and those invited to do so from a reviewer pool.

​​​​​​​​​Anti-Cancer Drugs报告与抗癌药物相关的临床和实验结果，并欢迎抗癌药物设计、药物递送、药理学、激素和生物模式以及化疗评估方面做出贡献。致力于快速发表关于抗癌药物、 抗癌药物的创新研究旨在刺激和报告对有毒和无毒抗癌剂的研究。该期刊的范围将涵盖传统的细胞毒性化学疗法和激素或生物反应方式，如白细胞介素和免疫疗法,目前期刊年发稿量在200篇左右，对国内相对友好。